Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash	$ 27,232	$ 14,774
Total Current Assets	27,232	14,774
Operating lease right-of-use asset	2,988	4,272
Security deposit	1,995	1,995
TOTAL ASSETS	32,215	21,041
Current Liabilities
Accounts payable and accrued liabilities	1,168,961	1,084,763
Shareholders’ notes payable	49,000	49,000
Operating lease liability – current portion	2,860	2,860
Accrued interest payable	21,199	19,279
Total Current Liabilities	2,670,178	2,319,968
Operating lease liability – long term portion	2,736	3,684
Total liabilities	2,672,914	2,323,652
Stockholder’s Deficit:
Preferred stock, $0.0001 par value; 40,000,000 shares authorized; Series F preferred stock - 3,000,000 shares designated, 0 issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value; 80,000,000 shares authorized; 18,843,628 shares issued and outstanding at June 30, 2026 and December 31, 2025	1,884	1,875
Additional paid-in capital	16,113,920	15,679,131
Stock subscription receivable		(125,000)
Accumulated deficit	(18,756,503)	(17,858,617)
Total Stockholders’ Deficit	(2,640,699)	(2,302,611)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	32,215	21,041
Sanovas Ophthalmology LLC [Member]
Current Liabilities
Due to related parties	996,007	674,842
Related Party [Member]
Current Liabilities
Due to related parties	$ 432,151	$ 489,224

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.